Rodman & Renshaw Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $12

BenzingaDec 12 05:03 ET · Ratings

FibroBiologics Files Patent Application For Cell-Based Therapeutic For Treatment Of Splenomegaly

BenzingaNov 19 09:16 ET

Promising Developments and Financial Stability Highlight FibroBiologics' Near-Term Opportunities

TipRanksNov 15 11:45 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaNov 14 16:10 ET

FibroBiologics Files Patent Application to Address IBMIR in Cell Therapies

Quiver QuantitativeNov 14 09:48 ET

Express News | Fibrobiologics Files Patent Application Covering Reduction of Blood Clots Associated With Instant Blood-Mediated Inflammatory Reaction (Ibmir) in Cell-Based Therapeutics

ReutersNov 14 09:15 ET